UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

The New England journal of medicine, 2017-03, Vol.376 (11), p.1015-1026

2017

Volltextzugriff (PDF)

Efficacy and safety of pembrolizumab in metastatic urothelial carcinoma: results from KEYNOTE-045 and KEYNOTE-052 after up to 5 years of follow-up

Annals of oncology, 2023-03, Vol.34 (3), p.289-299

2023

Volltextzugriff (PDF)

Analysis of Improved Nutritional Composition of Potential Functional Food (Okara) after Probiotic Solid-State Fermentation

Journal of agricultural and food chemistry, 2018-05, Vol.66 (21), p.5373-5381

2018

Volltextzugriff (PDF)

Phase II trial of everolimus for the treatment of nonclear-cell renal cell carcinoma

Annals of oncology, 2013-04, Vol.24 (4), p.1026-1031

2013

Volltextzugriff (PDF)

EV-301 long-term outcomes: 24-month findings from the phase III trial of enfortumab vedotin versus chemotherapy in patients with previously treated advanced urothelial carcinoma

Annals of oncology, 2023-11, Vol.34 (11), p.1047-1054

2023

Volltextzugriff (PDF)

Multicenter phase II study of sunitinib in patients with non-clear cell renal cell carcinoma

Annals of oncology, 2012-08, Vol.23 (8), p.2108-2114

2012

Volltextzugriff (PDF)

Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib

British journal of dermatology (1951), 2009-11, Vol.161 (5), p.1045-1051

2009

Volltextzugriff (PDF)

A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma

Annals of oncology, 2004-06, Vol.15 (6), p.947-954

2004

Volltextzugriff (PDF)

A randomised phase II study of modified FOLFIRI.3 vs modified FOLFOX as second-line therapy in patients with gemcitabine-refractory advanced pancreatic cancer

British journal of cancer, 2009-11, Vol.101 (10), p.1658-1663

2009

Volltextzugriff (PDF)

Characterizing the multi-dimensional reaction dynamics of dihalomethanes using XUV-induced Coulomb explosion imaging

The Journal of chemical physics, 2023-10, Vol.159 (14)

2023

Volltextzugriff (PDF)

First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC

British journal of cancer, 2014-04, Vol.110 (8), p.1917-1922

2014

Volltextzugriff (PDF)

Organic Depth Profiling of a Nanostructured Delta Layer Reference Material Using Large Argon Cluster Ions

Analytical chemistry (Washington), 2010-01, Vol.82 (1), p.98-105

2010

Volltextzugriff (PDF)

Thalamic adenylyl cyclase 1 is required for barrel formation in the somatosensory cortex

Neuroscience, 2015-04, Vol.290, p.518-529

2015

Volltextzugriff (PDF)

Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemia

Leukemia, 2015-10, Vol.29 (10), p.1981-1992

2015

Volltextzugriff (PDF)

Clinical heterogeneity of extranodal NK/T-cell lymphoma, nasal type: a national survey of the Korean Cancer Study Group

Annals of oncology, 2008-08, Vol.19 (8), p.1477-1484

2008

Volltextzugriff (PDF)

Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinum

British journal of cancer, 2012-03, Vol.106 (6), p.1039-1044

2012

Volltextzugriff (PDF)

Challenges to optimal rheumatology care: a patient-centered focus group study

Clinical rheumatology, 2020-10, Vol.39 (10), p.3083-3090

2020

Volltextzugriff (PDF)

Analysis of water-level response to rainfall and implications for recharge pathways in the Chalk aquifer, SE England

Journal of hydrology (Amsterdam), 2006-11, Vol.330 (3), p.604-620

2006

Volltextzugriff (PDF)

Evaluation of brewers’ spent grain as a novel media for yeast growth

AMB Express, 2017-06, Vol.7 (1), p.117-117, Article 117

2017

Volltextzugriff (PDF)

Neutrophil Toll-Like Receptor 9 Expression and the Systemic Inflammatory Response in Acetaminophen-Induced Acute Liver Failure

Critical care medicine, 2016-01, Vol.44 (1), p.43-53

2016

Volltextzugriff (PDF)

Digital intervention increases influenza vaccination rates for people with diabetes in a decentralized randomized trial

NPJ digital medicine, 2021-09, Vol.4 (1), p.138-138, Article 138

2021

Volltextzugriff (PDF)

Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up

Annals of oncology, 2019-06, Vol.30 (6), p.970-976

2019

Volltextzugriff (PDF)

Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma

Annals of oncology, 2020-08, Vol.31 (8), p.1030-1039

2020

Volltextzugriff (PDF)

A Mechanistic Model for Carbon Dioxide Corrosion of Mild Steel in the Presence of Protective Iron Carbonate Films—Part 3: Film Growth Model

Corrosion (Houston, Tex.), 2003-07, Vol.59 (7), p.616-628

2003

Volltextzugriff (PDF)

Psychological and pharmacological interventions for depression in patients with coronary artery disease

Cochrane database of systematic reviews, 2021-12, Vol.12 (12), p.CD008012-CD008012

2021

Volltextzugriff (PDF)

1 – 25 von 115.536

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(99.759)
Mit Volltextzugriff
(97.631)

Publikationsform

10 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(113.298)
Französisch
(1.544)
Japanisch
(176)
Koreanisch
(145)
Chinesisch
(118)
Deutsch
(88)
Russisch
(66)
Norwegisch
(52)
Spanisch
(44)
Portugiesisch
(23)
Niederländisch
(12)
Italienisch
(2)
Arabisch
(1)
Croatian
(1)
Dänisch
(1)
Türkisch
(1)
Welsh
(1)

12 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(77.083)
Life Sciences & Biomedicine
(50.461)
Humans
(36.710)
Female
(21.549)
Male
(21.179)
Biological And Medical Sciences
(20.187)
Physical Sciences
(17.694)
Medical Sciences
(14.736)
Technology
(14.646)
Animals
(14.296)
Middle Aged
(12.300)
Adult
(12.280)
Physics
(10.756)
Aged
(9.407)
Exact Sciences And Technology
(7.880)
Fundamental And Applied Biological Sciences. Psychology
(6.401)
Engineering
(5.665)
Mice
(5.545)
Chemistry
(5.175)
Biochemistry & Molecular Biology
(4.919)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(49.353)
EZB Electronic Journals Library
(46.282)
IngentaConnect
(44.128)
Journals@Ovid
(33.075)
NUS Single-Journal Subscriptions
(28.236)
Elsevier ScienceDirect Journals
(23.506)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(15.892)
Wiley Online Library Journals Frontfile Complete
(13.745)
IngentaConnect Journals
(13.033)
Wiley Online Library
(9.721)
Springer Nature - Complete Springer Journals
(8.419)
IEEE Electronic Library Online
(6.155)
Jstor Complete Legacy
(5.152)
Oxford journals
(5.136)
American Physical Society
(4.428)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(4.165)
Springer Nature - Connect here FIRST to enable access
(3.888)
PROLA - Physical Review
(3.798)
Oxford Journals 2020 Medicine
(3.510)
Taylor & Francis Journals
(2.748)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

Efficacy and safety of pembrolizumab in metastatic urothelial carcinoma: results from KEYNOTE-045 and KEYNOTE-052 after up to 5 years of follow-up

Analysis of Improved Nutritional Composition of Potential Functional Food (Okara) after Probiotic Solid-State Fermentation

Phase II trial of everolimus for the treatment of nonclear-cell renal cell carcinoma

EV-301 long-term outcomes: 24-month findings from the phase III trial of enfortumab vedotin versus chemotherapy in patients with previously treated advanced urothelial carcinoma

Multicenter phase II study of sunitinib in patients with non-clear cell renal cell carcinoma

Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib

A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma

A randomised phase II study of modified FOLFIRI.3 vs modified FOLFOX as second-line therapy in patients with gemcitabine-refractory advanced pancreatic cancer

Characterizing the multi-dimensional reaction dynamics of dihalomethanes using XUV-induced Coulomb explosion imaging

First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC

Organic Depth Profiling of a Nanostructured Delta Layer Reference Material Using Large Argon Cluster Ions

Thalamic adenylyl cyclase 1 is required for barrel formation in the somatosensory cortex

Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemia

Clinical heterogeneity of extranodal NK/T-cell lymphoma, nasal type: a national survey of the Korean Cancer Study Group

Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinum

Challenges to optimal rheumatology care: a patient-centered focus group study

Analysis of water-level response to rainfall and implications for recharge pathways in the Chalk aquifer, SE England

Evaluation of brewers’ spent grain as a novel media for yeast growth

Neutrophil Toll-Like Receptor 9 Expression and the Systemic Inflammatory Response in Acetaminophen-Induced Acute Liver Failure

Digital intervention increases influenza vaccination rates for people with diabetes in a decentralized randomized trial

Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up

Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma

A Mechanistic Model for Carbon Dioxide Corrosion of Mild Steel in the Presence of Protective Iron Carbonate Films—Part 3: Film Growth Model

Psychological and pharmacological interventions for depression in patients with coronary artery disease

Suchergebnisse filtern